Biogen Inc. buy Royal Bank of Canada
Start price
09.02.26
/
50%
€167.00
Target price
09.02.27
€197.12
Performance (%)
-11.70%
Price
10.04.26
€147.46
Summary
This prediction is currently active. The price of Biogen Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -11.70%. This prediction currently runs until 09.02.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | -4.122% | -4.122% |
| iShares Core DAX® | 2.554% | 0.562% |
| iShares Nasdaq 100 | 2.742% | -0.599% |
| iShares Nikkei 225® | 6.584% | 4.336% |
| iShares S&P 500 | 1.930% | -0.507% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen (NASDAQ:BIIB) had its price target raised by analysts at Royal Bank Of Canada from $217.00 to $233.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat